Regenerative Medical Technology Group Inc.: cashflow_financing
| Value | {"amount": 291381, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2026-01-01 – 2026-06-30 |
| Status | current |
| Entity | Regenerative Medical Technology Group Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-28T13:55:46.182922+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2a099c4b-f534-4c27-9746-423657d8ddce
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-26-091797Retrieved: 2026-08-28T13:55:46.182922+02:00
Raw response sha256:
fe1f8c053e07a6f20e5f7b99fc60e9be…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001760026/cashflow-financing/2026-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2a099c4b-f534-4c27-9746-423657d8ddce
History
- no predecessors — first report